- Report
- March 2024
- 189 Pages
Global
From €3262EUR$3,374USD£2,802GBP
€3624EUR$3,749USD£3,113GBP
- Report
- September 2023
- 180 Pages
Global
From €5752EUR$5,950USD£4,941GBP
- Report
- April 2024
- 89 Pages
Global
From €5414EUR$5,600USD£4,650GBP
- Report
- January 2024
- 200 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Report
- November 2023
- 146 Pages
Global
From €2416EUR$2,499USD£2,075GBP
- Report
- January 2024
- 182 Pages
Global
From €4737EUR$4,900USD£4,069GBP
- Report
- May 2022
- 228 Pages
Global
From €5076EUR$5,250USD£4,360GBP
- Report
- May 2023
- 90 Pages
Global
From €3500EUR$3,878USD£3,112GBP
- Report
- November 2022
- 132 Pages
Global
From €918EUR$950USD£789GBP
- Report
- February 2024
- 199 Pages
Global
From €3480EUR$3,600USD£2,990GBP
The Blood Derivative market is a subset of the Blood Banking industry, which involves the collection, processing, storage, and distribution of human blood and its components. Blood derivatives are products derived from human blood, such as plasma, platelets, and red blood cells. These products are used to treat a variety of medical conditions, including anemia, cancer, and trauma.
The Blood Derivative market is highly regulated, with stringent safety and quality standards in place to ensure the safety of the products. The market is also highly competitive, with a number of companies offering a variety of products and services.
Some of the major players in the Blood Derivative market include CSL Behring, Grifols, Octapharma, Kedrion, and Biotest. These companies are involved in the production, distribution, and marketing of blood derivatives, as well as providing related services. Show Less Read more
